Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1978 Aug;6(2):155-62.
doi: 10.1111/j.1365-2125.1978.tb00841.x.

Drowsiness, impaired performance and tricyclic antidepressants drugs

Clinical Trial

Drowsiness, impaired performance and tricyclic antidepressants drugs

C Bye et al. Br J Clin Pharmacol. 1978 Aug.

Abstract

1. The effects of amitriptyline, protriptyline, protriptyline, and a chemically related potential antidepressant, BW247, on performance tests and subjective ratings were studied. 2. Two groups of twelve healthy subjects received drugs and lactose dummy in identical capsules at weekly intervals according to a balanced design, under double-blind conditions, and with standarized tests and environment. 3. Amitriptyline produced the most marked effects, with significant (P less than 0.05) impairment in auditory vigilance after 6.25 mg. Auditory reaction time, tapping rate, arithmetic, and digit symbol substitutions were impaired by amitriptyline 12.5 and 25 mg and all doses produced increased ratings of mental sedation. The effects began 1.5 h after drug and lasted approximately 5 h. 4. Nortriptyline produced fewer effects which were later in onset. Tapping at 1.8 h and auditory vigilance at 3.5 to 4.5 h were impaired by nortriptyline 25 mg whereas reaction time was prolonged by both doses at 5 h. No change in rating of mental sedation occurred. 5. No significant change in performance or subjective ratings followed protriptyline 10 mg or BW247, 12.5 and 25 mg. 6. The findings are discussed in relation to the presence of secondary and tertiary amines on the side chain of the compounds, and their relative abilities to block neuronal uptake of noradrenaline and 5-hydroxytryptamine.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Int J Neuropharmacol. 1964 Dec;3:611-21 - PubMed
    1. Scott Med J. 1964 Aug;9:341-4 - PubMed
    1. Ann N Y Acad Sci. 1962 Jan 13;96:279-88 - PubMed
    1. Eur J Clin Pharmacol. 1975 Aug 14;8(6):455-63 - PubMed
    1. Eur J Clin Pharmacol. 1975 Jun 13;8(5):343-7 - PubMed

Publication types

Substances

LinkOut - more resources